Why is Metropolis Healt falling/rising?

As of 15-Jul, Metropolis Healthcare Ltd's stock price is currently at Rs 1,871.00, reflecting a decrease of Rs 11.0 or 0.58%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 9.1% during this period. Today's performance indicates that it has underperformed its sector by 2.02%. Additionally, the stock's intraday low reached Rs 1,828.95, which is a 2.82% drop. While the stock has shown a positive return of 10.06% over the past month, it has experienced a significant decline of 9.32% year-to-date and 9.56% over the past year. Factors contributing to this decline include poor long-term growth metrics, with net sales growing at an annual rate of only 9.22% and operating profit at a mere 0.10% over the last five years. Despite high management efficiency and institutional holdings, the stock's valuation appears expensive relative to its fundamentals.
In the broader market context, Metropolis Healthcare Ltd's recent performance contrasts with the benchmark Sensex, which has declined by 1.36% over the past week while the stock itself has gained 0.27%. However, the stock's year-to-date performance is notably worse than the Sensex, which has increased by 5.67%. The falling investor participation, evidenced by a 38.95% drop in delivery volume, further indicates a lack of confidence among investors. The company's recent negative financial results, including a significant drop in PAT and low ROCE, contribute to the overall bearish sentiment surrounding the stock, despite its relatively high institutional ownership which typically suggests a more stable investment.